Every GIST patient is unique based on their biology and what treatment to which they will potentially respond. Dr. Lori Rink, Fox Chase Cancer Center, and Dr. Inga-Marie Schaefer, Brigham & Women’s Hospital, are two researchers who are making discoveries in their respective laboratories to uncover the unique biomarkers in GIST that will be future drug targets.
This webinar is for all GIST patients around the world. Hosted by SPAEN (Sarcoma Patients EuroNet Association), this two hour New Horizons GIST presentation will focus on mutational testing in GIST as a guide [...]
August 12th, 12-1pm ET The Life Raft Group is partnering with Dr. Michael Wagner from the University of Washington to present “The Importance of Biomarker Testing” to GIST patients and caregivers on August 12th, [...]